Hipzol 1 SR Tablet contains Alprazolam 1mg, a benzodiazepine primarily indicated for the management of anxiety disorders, panic disorders, and anxiety associated with depression. Alprazolam acts on the central nervous system by enhancing the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, thereby producing a calming effect. The sustained-release formulation of Hipzol 1 SR allows for a gradual release of the active ingredient, providing prolonged therapeutic effects and reducing the frequency of dosing, which may improve patient compliance. This medication is typically prescribed for short-term use due to the potential for tolerance, dependence, and withdrawal symptoms associated with benzodiazepines. Common adverse effects include drowsiness, dizziness, fatigue, and impaired coordination. Caution is advised when administering Hipzol 1 SR to patients with a history of substance abuse, respiratory insufficiency, or hepatic impairment. It is contraindicated in individuals with hypersensitivity to Alprazolam or other benzodiazepines, and concurrent use with alcohol or other CNS depressants should be avoided to prevent enhanced sedative effects. Dosage adjustments should be individualized based on clinical response and patient tolerance, and abrupt discontinuation should be avoided to minimize withdrawal risks. Always consult a healthcare professional before initiating or discontinuing therapy with Hipzol 1 SR Tablet.